User menu

A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients.

Bibliographic reference Wijermans, P ; Ferrant, Augustin ; Lubbert, M ; Verhoef, G. ; Bosly, André ; et. al. A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients..In: Blood, Vol. 92, no. 10, p. 632A-632A (1998)
Permanent URL http://hdl.handle.net/2078.1/62387